Skip to main content

Rosario Pardo Diaz

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rosario Pardo Diaz

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Diabetis i metabolisme

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Rosario Pardo Diaz, Angel Michael Ortiz Zúñiga, Andreea Ciudin Mihai, Fiorella Ximena Palmas Candia, Ana Maria Ortiz de Urbina Olive, Monica Sanchez Bartres, Lorena Ramos Pérez, Marc Rivas Agudo, Diabetis i metabolisme, Anna Casteras Román, Alejandra Planas Vilaseca, Betina Biagetti Biagetti, Judit Amigó Farran, Mercè Abad Martín, Marta Comas Martínez, Hugo Ramos Abellan, Rosa Burgos Peláez, David Sabater Martínez, Olga Simó Servat, Patricia Bogdanov Baruj, Maria Llorian Salvador, Enzamaría Fidilio Meli
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00655
Duration: 01/01/2022 - 30/06/2025

OBESIMM - Explorando los efectos de la alimentación restringida en el tiempo sobre la funcióin inmune de individuos obesos: una aproximación multi-ómica

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz, Andreea Ciudin Mihai, Marta Comas Martínez, Ramón Vilallonga Puy, Enzamaría Fidilio Meli
Funding agency: Instituto de Salud Carlos III
Funding: 248050
Reference: AC22/00023
Duration: 01/01/2023 - 31/12/2025

Control of the adipose-pancreatic crosstalk by mitochondrial metabolism in adipose tissues: implications in the development of diet-induced type 2 diabetes

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz, Berta Pares Bofill, Irene Hernández Hernández
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 145200
Reference: RTI2018-099250-B-I00
Duration: 01/01/2019 - 30/09/2022

Bases moleculares de la restricción calórica: papel de los coactivadores PGC-1 en tejido adiposo

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 105300
Reference: SAF2012-39484
Duration: 01/01/2013 - 31/12/2015

Related news

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Related professionals

Christina Regales Peco

Christina Regales Peco

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Marc Rivas Agudo

Marc Rivas Agudo

Diabetes and Metabolism
Read more
Anna  Pascual  Carreño

Anna Pascual Carreño

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Montserrat Aguilera Pujabet

Montserrat Aguilera Pujabet

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.